Key insights from lung cancer research at ASCO 2025
Dr Eulade Rugengamanzi delves into the topic of multiple myeloma, a malignant disease marked by an excess of SMMA cells in the bone marrow. He explores its incidence, risk factors, signs and symptoms, pathophysiology, diagnostic investigations, and treatment options.
Key insights from lung cancer research at ASCO 2025
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Advancements in paediatric Acute lymphoblastic leukemia management
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Relapsed refractory multiple myeloma
Multiple myeloma (A cancer arising from plasma cells)
Lung Cancer